Waypoint Bio co-founders and Xinchen Wang (L) and David Phizicky (Credit: Waypoint Bio)

Ex­clu­sive: To de­vel­op bet­ter cell ther­a­pies for sol­id tu­mors, a new start­up plans to test hun­dreds of them at once

Ther­a­pies made from a pa­tient’s own im­mune cells have spurred med­ical mir­a­cles for many peo­ple with ad­vanced blood can­cers, but get­ting those CAR-T cell ther­a­pies …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.